Yıl: 2022 Cilt: 28 Sayı: 1 Sayfa Aralığı: 56 - 61 Metin Dili: İngilizce DOI: 10.21613/GORM.2022.1278 İndeks Tarihi: 08-06-2022

Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction

Öz:
BJECTIVE: This study aimed to evaluate the severity of nausea vomiting of pregnancy in assisted reproductive technologies pregnancies using the Pregnancy-Unique Quantification of Emesis scoring system which is a validated, clinically relevant method to assess nausea vomiting of pregnancy severity. STUDY DESİGN: A total of 101 pregnant women between 8+0-14+6 weeks of gestation were enrolled in this case-control study. Of these women, 53 had pregnancies conceived via assisted reproductive technologies (study group) and 48 had pregnancies conceived naturally (control group). The PregnancyUnique Quantification of Emesis-24 scale was utilized to evaluate nausea vomiting of pregnancy severity in both groups. Weight change during pregnancy and hospital admission due to nausea vomiting of pregnancy were also compared to assess severe nausea vomiting of pregnancy. RESULTS: According to the Pregnancy-Unique Quantification of Emesis scale, 67.9% of patients with assisted reproductive technologies pregnancies experienced mild nausea vomiting of pregnancy while 24.5% had moderate and 7.5% had severe nausea vomiting of pregnancy. In the spontaneous pregnancies group, 60.4% experienced mild nausea vomiting of pregnancy, 33.3% had moderate nausea vomiting of pregnancy and only 6.3% had severe nausea vomiting of pregnancy. The overall PregnancyUnique Quantification of Emesis score was 5 (3-8.5) in assisted reproductive technologies pregnancies and 5 (3-10) in spontaneous pregnancies (p=0.650). There was no statistically significant difference regarding hospitalization history due to nausea vomiting of pregnancy between assisted reproductive technologies and naturally-conceived pregnancies (p=0.619). CONCLUSION: Conception using assisted reproductive technologies does not increase nausea vomiting of pregnancy severity. Furthermore, weight change during pregnancy and hospitalization rates due to nausea vomiting of pregnancy were comparable between women conceived with assisted reproductive technologies and women with natural conception.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Verberg MFG, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005;11(5):527-39. Doi: 10.1093/ humupd/dmi021.
  • 2. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002; 186(5 Suppl Understanding):S228-31. Doi: 10.1067/ mob.2002.123054.
  • 3. Koren G, Piwko C, Ahn E, Boskovic R, Maltepe C, Einarson A, et al. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol. 2005;25(3):241-4. Doi: 10.1080/0144361050 0060651.
  • 4. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2008;198(1):71e1-7. Doi: 10.1016/j.ajog.2007.05.051.
  • 5. Ebrahimi N, Maltepe C, Bournissen FG, Koren G. Nausea and vomiting of pregnancy: using the 24-hour PregnancyUnique Quantification of Emesis (PUQE-24) scale. J Obstet Gynaecol Can. 2009;31(9):803-7. Doi: 10.1016/ S1701-2163(16)34298-0.
  • 6. O’Leary P, Boyne P, Flett P, Beilby J, James I. Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem. 1991;37(5): 667-72. PMID: 1827758.
  • 7. Talaulikar VS, Arulkumaran S. Reproductive outcomes after assisted conception. Obstet Gynecol Surv. 2012; 67(9):566-83. Doi: 10.1097/OGX.0b013e31826 a5d4a.
  • 8. Maymon R, Shulman A. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons. Hum Reprod. 2002;17(4): 1081-5. Doi: 10.1093/humrep/17.4.1081.
  • 9. Bar-Hava I, Yitzhak M, Krissi H, Shohat M, Shalev J, Czitron B, Ben-Rafael Z, Orvieto R. Triple-test screening in in vitro fertilization pregnancies. J Assist Reprod Genet. 2001;18(4):226-9. Doi: 10.1023/a:1009455912670.
  • 10. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. Down’s syndrome screening marker levels following assisted reproduction. Prenat Diagn. 1996;16(12):1111-4. Doi: 10.1002/(SICI)1097-0223(199612)16:12<1111: AID-PD998>3.0.CO;2-X.
  • 11. Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down’s syndrome screening. Fertil Steril. 1996;66(3):398-403. Doi: 10.1016/s0015-0282(16)58508-2.
  • 12. Lee NM, Saha S. Nausea and vomiting of pregnancy. Gastroenterol Clin North Am. 2011;40(2):309-34, vii. Doi: 10.1016/j.gtc.2011.03.009.
  • 13. Mostinckx L, Segers I, Belva F, Buyl R, Santos-Ribeiro S, Blockeel C, et al. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation. Hum Reprod. 2019;34(8):1595-607. Doi: 10.1093/humrep/ dez086.
  • 14. Bordi G, D’Ambrosio A, Gallotta I, Di Benedetto L, Frega A, Torcia F, et al. The influence of ovulation induction and assisted conception on maternal and perinatal outcomes of twin pregnancies. Eur Rev Med Pharmacol Sci. 2017;21(18):3998-4006. PMID: 29028104.
  • 15. Caserta D, Bordi G, Stegagno M, Filippini F, Podagrosi M, Roselli D, et al. Maternal and perinatal outcomes in spontaneous versus assisted conception twin pregnancies. Eur J Obstet Gynecol Reprod Biol. 2014;174:64-9. Doi: 10.1016/j.ejogrb.2013.12.011.
  • 16. Koudstaal J, Braat DD, Bruinse HW, Naaktgeboren N, Vermeiden JP, Visser GH. Obstetric outcome of singleton pregnancies after IVF: a matched control study in four Dutch university hospitals. Hum Reprod. 2000;15(8): 1819-25. Doi: 10.1093/humrep/15.8.1819.
  • 17. Dypvik J, Pereira AL, Tanbo TG, Eskild A. Maternal human chorionic gonadotrophin concentrations in very early pregnancy and risk of hyperemesis gravidarum: A retrospective cohort study of 4372 pregnancies after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2018;221:12-6. Doi: 10.1016/j.ejogrb.2017.12.015.
  • 18. Roseboom TJ, Ravelli AC, van der Post JA, Painter RC. Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2011;156(1):56-9. Doi: 10.1016/j. ejogrb.2011.01.010.
  • 19. Nurmi M, Rautava P, Gissler M, Vahlberg T, PoloKantola P. Incidence and risk factors of hyperemesis gravidarum: A national register-based study in Finland, 2005-2017. Acta Obstet Gynecol Scand. 2020;99(8): 1003-13. Doi: 10.1111/aogs.13820.
  • 20. Koot MH, Grooten IJ, van der Post JAM, Bais JMJ, RisStalpers C, Leeflang MMG. et al. Determinants of disease course and severity in hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2020;245:162-7. Doi: 10.1016/j.ejogrb.2019.12.021.
  • 21. Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes Å, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019;5(1):62. Doi: 10.1038/s41572-019-0110-3.
APA YÜCEL ÇİÇEK Ö, Demir M (2022). Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. , 56 - 61. 10.21613/GORM.2022.1278
Chicago YÜCEL ÇİÇEK Özge Senem,Demir Merve Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. (2022): 56 - 61. 10.21613/GORM.2022.1278
MLA YÜCEL ÇİÇEK Özge Senem,Demir Merve Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. , 2022, ss.56 - 61. 10.21613/GORM.2022.1278
AMA YÜCEL ÇİÇEK Ö,Demir M Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. . 2022; 56 - 61. 10.21613/GORM.2022.1278
Vancouver YÜCEL ÇİÇEK Ö,Demir M Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. . 2022; 56 - 61. 10.21613/GORM.2022.1278
IEEE YÜCEL ÇİÇEK Ö,Demir M "Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction." , ss.56 - 61, 2022. 10.21613/GORM.2022.1278
ISNAD YÜCEL ÇİÇEK, Özge Senem - Demir, Merve. "Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction". (2022), 56-61. https://doi.org/10.21613/GORM.2022.1278
APA YÜCEL ÇİÇEK Ö, Demir M (2022). Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. GORM:Gynecology Obstetrics & Reproductive Medicine, 28(1), 56 - 61. 10.21613/GORM.2022.1278
Chicago YÜCEL ÇİÇEK Özge Senem,Demir Merve Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. GORM:Gynecology Obstetrics & Reproductive Medicine 28, no.1 (2022): 56 - 61. 10.21613/GORM.2022.1278
MLA YÜCEL ÇİÇEK Özge Senem,Demir Merve Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. GORM:Gynecology Obstetrics & Reproductive Medicine, vol.28, no.1, 2022, ss.56 - 61. 10.21613/GORM.2022.1278
AMA YÜCEL ÇİÇEK Ö,Demir M Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. GORM:Gynecology Obstetrics & Reproductive Medicine. 2022; 28(1): 56 - 61. 10.21613/GORM.2022.1278
Vancouver YÜCEL ÇİÇEK Ö,Demir M Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction. GORM:Gynecology Obstetrics & Reproductive Medicine. 2022; 28(1): 56 - 61. 10.21613/GORM.2022.1278
IEEE YÜCEL ÇİÇEK Ö,Demir M "Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction." GORM:Gynecology Obstetrics & Reproductive Medicine, 28, ss.56 - 61, 2022. 10.21613/GORM.2022.1278
ISNAD YÜCEL ÇİÇEK, Özge Senem - Demir, Merve. "Evaluation of Nausea and Vomiting Severity in Pregnancies Conceived Through Assisted Reproduction". GORM:Gynecology Obstetrics & Reproductive Medicine 28/1 (2022), 56-61. https://doi.org/10.21613/GORM.2022.1278